Grossman William
- SEC CIK
- 0001730229
In the past year, 1 open-market purchase filing worth $10.1K and no sales.
Current role at each company
- ENGN enGene Therapeutics Inc.Interim Chief Medical Officeras of Sep 24, 2026
- DAWN Day One Biopharmaceuticals, Inc.Directoras of Apr 23, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $10.1K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$10.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Grossman William as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ENGN enGene Therapeutics Inc.
Interim Chief Medical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 (view filing)4:40 PM ET | Sep 22 | 2 days | Grossman WilliamInterim Chief Medical Officer | PPurchase | +5.10K | $1.97 | +$10.1K | New position5.10K after |